Multiple Psychotropic Medication Use for Youths: A Two-State Comparison
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The aim of this study was to compare multiple psychotropic use among youths enrolled in two U.S. mid-Atlantic state Medicaid and state Children's Health Insurance Programs (SCHIP). METHODS: Administrative data were used to examine multiple psychotropic use among youths less than 20 years of age and who were continuously enrolled in Medicaid or SCHIP programs in two states during 1999. Multiple psychotropic use referred to multiclass combinations and was defined by the number of months of multiple use. Main outcome measures were the prevalence of multiple psychotropic use and months of multiple use. Demographic and clinical characteristics, mental health visits, and common combinations were examined according to months of multiple use. RESULTS: Among continuously enrolled youths, 21%-22% had at least one mental health-related visit, 8%-10% received a psychotropic medication, and 2%-3% received multiple psychotropic medications. Nearly one third (28%-30%) of youths with any psychotropic use received multiple medications, of which almost half was for 5-12 months. Multiclass use was more common in male, white, aged 10-14, disabled, and foster-care youths. Stimulants with antidepressants, antipsychotics, or alpha-agonists were the most common combinations. CONCLUSIONS: Multiple use occurred in nearly one third of youths with any psychotropic treatment. Additional research is needed to investigate switching patterns and the effectiveness of combined pharmacotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ADHD Comorbidity Findings From the MTA Study: Comparing Comorbid Subgroups
JENSEN, P. S., HINSHAW, S. P., KRAEMER, H. C., LENORA, N., NEWCORN, J. H., ABIKOFF, H. B., MARCH, J. S., ARNOLD, L. E., CANTWELL, D. P., CONNERS, C. K., et al. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200102000-00009 · Cited by 974
Psychotherapeutic medication patterns for youths with attention-deficit/hyperactivity disorder
Zito, J. M., Safer, D. J., dosReis, S., Magder, L. S., Gardner, J. F., & Zarin, D. A. (1999) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.153.12.1257 · Cited by 162 · cited 4×
“Combined pharmacotherapy with alpha- agonists has been noted by others (Bhatara et al. 2002; Efron et al. 2003; Martin et al. 2003; Zima et al. 1999; Zito et al. 1999), and our study suggests such combinations were one-quarter of multiclass usage.”
InfluentialSelf-citationDatapoints: use of multiple psychotropic drugs by Medicaid-insured and privately insured children.
Martin, A., Sherwin, T., Stubbe, D., Van Hoof, T., Scahill, L., & Leslie, D. (2002) · Psychiatric Services · doi:10.1176/appi.ps.53.12.1508 · Cited by 24 · cited 2×
“2002), gender, physician specialty, and insurance coverage (Martin et al. 2002; Safer et al. 2003) have been noted.”
Cited by
Psychotropic medication use among Medicaid-enrolled children with autism spectrum disorders
Mandell, D. S., Morales, K. H., Marcus, S. C., Stahmer, A. C., Doshi, J., & Polsky, D. E. (2008) · Pediatrics · doi:10.1542/peds.2007-0984 · Cited by 295
Potential adverse effects of amphetamine treatment on brain and behavior: a review
Berman, S. M., Kuczenski, R., McCracken, J. T., & London, E. D. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.90 · Cited by 261
Psychotropic Medication Patterns Among Youth in Foster Care
Zito, J. M., Safer, D. J., Sai, D., Gardner, J. F., Thomas, D., Coombes, P., Dubowski, M., & Mendez-Lewis, M. (2008) · Pediatrics · doi:10.1542/peds.2007-0212 · Cited by 254
Self-citationComer, J. S., Olfson, M., & Mojtabai, R. (2010) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2010.07.007 · Cited by 252
Logan, S. L., Nicholas, J. S., Carpenter, L. A., King, L. B., Garrett-Mayer, E., & Charles, J. M. (2012) · Annals of Epidemiology · doi:10.1016/j.annepidem.2011.10.007 · Cited by 65
Metadata
- Authors
- dosReis, S., Zito, J. M., Safer, D. J., Gardner, J. F., Puccia, K. B., & Owens, P. L.
- Venue
- Journal of Child and Adolescent Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2005-02
- Volume
- 15
- Issue
- 1
- Pages
- 68-77
- ISSN
- 1044-5463 (ISSN-L)
- 1557-8992
- OpenAlex
- W2006930741
- Cited by
- 72
- References
- 3
- FWCI
- 2.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.